First AD

Second AD

Non-Hodgkin Lymphoma

The OncLive Non-Hodgkin Lymphoma condition center page is a comprehensive resource for clinical news and expert insights on various types of non-Hodgkin lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in non-Hodgkin lymphoma.

Hematologic Oncology

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Optimizing Treatment of Follicular Lymphoma 

Peer Exchange

Treatment Options After Second-Line Relapse

Differential Diagnosis and Staging of Follicular Lymphoma

The Importance of Risk Assessment

When to Initiate Therapy for Follicular Lymphoma

Immunochemotherapy Decision Factors

Phase III GALLIUM Results and Maintenance Therapy

Determining Second-Line Therapy in FL

Relapsed/Refractory Treatment: The MAGNIFY Regimen

The DYNAMO Later-Line Regimen

Sequencing Strategies for Later-Line Therapy

The Phase II EZH2 Inhibitor Trial

Previously Untreated FL: Obinutuzumab Plus Lenalidomide

The Phase III GADOLIN Trial

Phase Ib Polatuzumab Vedotin Trial

The Future Landscape of Follicular Lymphoma Treatment